Ebola vaccine

Ebola Vaccine

The Ebola vaccine (pronounced /iːˈboʊlə/), also known as rVSV-ZEBOV, is a vaccine used to prevent Ebola.

Etymology

The term "Ebola" originates from the Ebola River in the Democratic Republic of Congo, where the virus was first identified in 1976. The term "vaccine" comes from the Latin vaccinus, meaning "of or from the cow", due to the early practice of using cowpox to immunize against smallpox.

Usage

The Ebola vaccine is used to protect individuals from contracting the Ebola virus, a severe and often fatal illness in humans. The vaccine is administered as a single dose by injection, and it has been shown to be effective in preventing infection if administered shortly after exposure.

Development

The Ebola vaccine was developed by the Public Health Agency of Canada, with production later taken over by Merck & Co.. The vaccine was fast-tracked for approval by the World Health Organization (WHO) and the U.S. Food and Drug Administration (FDA) during the 2014-2016 Ebola outbreak in West Africa.

Related Terms

• Vaccine
• Ebola
• Merck & Co.
• World Health Organization
• U.S. Food and Drug Administration

External links

• Medical encyclopedia article on Ebola vaccine
• Wikipedia's article - Ebola vaccine

This WikiMD dictionary article is a stub. You can help make it a full article.

---

Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski